Published in Am J Epidemiol on April 01, 1981
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep (1993) 1.70
Epidemiology of a tuberculosis outbreak in a South Carolina junior high school. Am J Public Health (1985) 1.14
Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis. Thorax (1998) 0.99
Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int J Tuberc Lung Dis (2010) 0.98
Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Nat Commun (2015) 0.97
Public health impact of targeted tuberculosis screening in public schools. Am J Public Health (2002) 0.87
Restriction fragment length polymorphism typing of Mycobacterium tuberculosis. Thorax (1995) 0.82
Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife (2016) 0.80
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98
Nationwide survey of drug-resistant tuberculosis in the United States. JAMA (1994) 6.14
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66
Tuberculosis in the United States. JAMA (1989) 5.12
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA (1994) 4.44
The new tuberculosis. N Engl J Med (1992) 4.37
Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06
Extrapulmonary tuberculosis in the United States. Am J Epidemiol (1979) 3.53
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48
Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis (1978) 3.15
Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis (1990) 2.81
Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53
Epidemiology of tuberculosis in the United States. Epidemiol Rev (1989) 2.23
Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15
The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis (1979) 2.13
Tuberculosis in the 1980s. N Engl J Med (1980) 2.09
Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis (1999) 2.05
The relationship between tuberculosis and silicosis. Am Rev Respir Dis (1978) 1.89
The tuberculin skin test. Am Rev Respir Dis (1982) 1.75
Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA (1980) 1.74
Foreign-born persons with tuberculosis in the United States. Am J Public Health (1981) 1.73
Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland. Am Rev Respir Dis (1982) 1.69
The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med (1982) 1.68
Current tuberculosis screening practices. Am J Public Health (1984) 1.67
Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole. J Infect Dis (1995) 1.60
The usefulness of phage typing Mycobacterium tuberculosis isolates. Am Rev Respir Dis (1984) 1.58
Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med (1990) 1.57
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56
Extrapulmonary tuberculosis in Oklahoma, 1965 to 1973. Am Rev Respir Dis (1975) 1.54
The epidemiology of tuberculosis in the United States. Semin Respir Infect (1989) 1.52
Declining fertility in England and Wales as a major cause of the twentieth century decline in mortality. The role of changing family size and age structure in infectious disease mortality in infancy. Am J Epidemiol (1985) 1.49
The rising age of the tuberculosis patient: a sign of success and failure. J Infect Dis (1980) 1.48
Treatment of tuberculosis during pregnancy. Am Rev Respir Dis (1980) 1.46
Simulated bone metastases: a case study of two patients with breast cancer. Australas Radiol (1999) 1.45
Tuberculosis and acquired immunodeficiency syndrome--Florida. Arch Intern Med (1989) 1.45
Postoperative radiotherapy for Dukes' B and C rectal cancer: Peter MacCallum Cancer Institute experience. Australas Radiol (1996) 1.38
The need for epidemic intelligence. Public Health Rep (1996) 1.35
Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA (1985) 1.33
Tuberculosis among Indochinese refugees in the United States. JAMA (1983) 1.32
Tuberculosis diagnosed at death in the United States. Chest (1991) 1.31
A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis (1978) 1.25
Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial. Am Rev Respir Dis (1984) 1.25
A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet Cell Genet (1995) 1.22
Study of middle ear disease using tympanometry in general practice. Br Med J (Clin Res Ed) (1985) 1.21
Tuberculosis control among homeless populations. Arch Intern Med (1988) 1.21
Drug-resistant tuberculosis. Am Rev Respir Dis (1991) 1.20
U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis. Am Rev Respir Dis (1979) 1.20
Pyridoxine supplementation during isoniazid therapy. Tubercle (1980) 1.18
The global threat of drug-resistant tuberculosis. N Engl J Med (1998) 1.17
The epidemiology of tuberculosis in the United States. Implications for diagnosis and treatment. Clin Chest Med (1989) 1.16
Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep (1990) 1.16
Association between HTLV-III/LAV infection and tuberculosis in Zaire. JAMA (1986) 1.15
Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis (1980) 1.14
Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep (1989) 1.13
Enhancing patient compliance with tuberculosis therapy. Clin Chest Med (1989) 1.13
Tuberculosis and the acquired immunodeficiency syndrome. Chest (1986) 1.11
Tuberculin skin testing of hospital employees: infection, "boosting," and two-step testing. Am J Infect Control (1984) 1.10
Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan. Am J Respir Crit Care Med (2000) 1.09
The good news and the bad news about multidrug-resistant tuberculosis. Clin Infect Dis (1995) 1.09
Tuberculosis in the foreign born. Am Rev Respir Dis (1977) 1.08
Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure. JAMA (1985) 1.07
Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis (1984) 1.07
Drug resistance among previously treated tuberculosis patients, a brief report. Am Rev Respir Dis (1980) 1.05
How much tuberculosis in children must we accept? Am J Public Health (1986) 1.04
An assessment of the possible association of isoniazid with human cancer deaths. Am Rev Respir Dis (1977) 1.01
Tuberculosis and gastrectomy. Chest (1985) 1.01
Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med (1994) 1.01
Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing. Proc Natl Acad Sci U S A (1996) 0.98
A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther (2000) 0.98
Recent trends in tuberculosis in children. JAMA (1984) 0.96
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. Br J Cancer (2002) 0.96
Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey. Am J Public Health (1988) 0.95
Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics (1983) 0.94
Three-probe fluorescence in situ hybridization to assess chromosome X, Y, and 8 aneuploidy in sperm of 14 men from two healthy groups: evidence for a paternal age effect on sperm aneuploidy. Reprod Fertil Dev (1995) 0.94
A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study. Am Rev Respir Dis (1976) 0.94
Evaluation of tuberculosis control programs: some national trends. Am J Public Health (1984) 0.93
American Thoracic Society. Medical Section of the American Lung Association. Guidelines for short-course tuberculosis chemotherapy. Am Rev Respir Dis (1980) 0.92
Incentives to take up health services. Lancet (1986) 0.92
Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet (1998) 0.91
Low-dose caudal morphine for postoperative analgesia in infants and children: a report of 500 cases. J Clin Anesth (1995) 0.91
Standard therapy for tuberculosis 1985. Chest (1985) 0.90
The Ottawa County project: a report of a tuberculosis screening project in a small mining community. Am J Public Health (1979) 0.90
Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases. Rev Infect Dis (1987) 0.90
Chemoprophylaxis. Am Rev Respir Dis (1982) 0.89
Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutat Res (2006) 0.89
United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide. Tubercle (1987) 0.89
Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase. Biochem J (1977) 0.89